Includes index.

REFERENCES -- Chapter 7 Drugs to T reat Affective Disorders: Depression and Bipolar Syndrome -- DEPRESSION -- Pathophysiology of Depression -- Antidepressant Drugs -- Pharmacokinetics of Antidepressants -- Problems and Adverse Effects -- Antidepressants and Chronic Pain -- BIPOLAR DISORDER -- Lithium -- Other Drugs for Bipolar Disorder -- Special Concerns for Rehabilitation Patients -- CASE STUDY -- ANTIDEPRESSANT DRUGS -- SUMMARY -- REFERENCES -- Chapter 8 Antipsychotic Dr ugs -- SCHIZOPHRENIA -- Pathogenesis of Schizophrenia -- Neurotransmitter Changes in Schizophrenia -- ANTIPSYCHOTICS MECHANISM OF ACTION -- ANTIPSYCHOTIC DRUGS -- Traditional Antipsychotics -- Atypical Antipsychotics -- PHARMACOKINETICS -- OTHER USES OF ANTIPSYCHOTICS -- PROBLEMS AND ADVERSE EFFECTS -- Extrapyramidal Symptoms -- Nonmotor Effects -- Other Side Effects -- Special Concerns for Rehabilitation Patients -- CASE STUDY -- ANTIPSYCHOTIC DRUGS -- SUMMARY -- REFERENCES -- Chapter 9 Antiepileptic Drugs -- CLASSIFICATION OF EPILEPTIC SEIZURES -- RATIONALE FOR DRUG TREATMENT -- ANTISEIZURE DRUGS -- First-Generation Antiseizure Drugs -- Second-Generation Agents -- SELECTION OF A SPECIFIC ANTIEPILEPTIC AGENT -- PHARMACOKINETICS -- SPECIAL PRECAUTIONS DURING PREGNANCY -- TREATMENT OF STATUS EPILEPTICUS -- WITHDRAWAL OF ANTISEIZURE MEDICATIONS -- Special Concerns for Rehabilitation Patients -- CASE STUDY -- ANTIEPILEPTIC DRUGS -- SUMMARY -- REFERENCES -- Chapter 10 Pharmacological Management of Parkinson Disease -- PATHOPHYSIOLOGY OF PARKINSON DISEASE -- ETIOLOGY OF PARKINSON DISEASE: GENETIC AND ENVIRONMENTAL FACTORS -- Genetic Factors -- Environmental Factors -- THERAPEUTIC AGENTS IN PARKINSONISM -- Levodopa -- Pharmacokinetics of Levodopa -- Use of Peripheral Decarboxylase Inhibitors -- Problems and Adverse Effects of Levodopa Therapy -- Drug Holidays From Levodop